ShareValue scores for HIVE.TA: Valuation 50, Quality 50, Growth 50, Health 50.
HIVE.TATASE
Hive 2040 R&D Limited Partnership
₪125.10
(0.00%)
HIVE.TATASE
Hive 2040 R&D Limited Partnership
₪125.10(0.00%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 16%
Rating
Trap Risk
Return
6% to 16%
Valuation
50
Fair Value
Price vs Value
Quality
50
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
50
Moderate
Financial Stability
Momentum
52
Neutral
Price Trend
Company Details
About
Hive 2040 R&D Limited Partnership operates as a research and development VC fund. The company is based in Israel.
Market Cap$402M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1617
Score Analysis
AI Investment Thesis
Data as of:Jun 29, 2026
|Last calculated:Jun 29, 2026